OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
UNPH56

Uniphos Enterprises Ltd

Commodity ChemicalsVerified

Uniphos Enterprises Ltd exhibits a highly liquid capital structure, with a current ratio of 8.83, indicating strong short-term liquidity. The company holds INR 71.19 million in cash and equivalents, while its total liabilities amount to INR 1.00 billion, with no long-term debt outstanding. This liquidity position is supported by a debt-to-equity ratio of 0.0, suggesting no leverage in its capital structure. Profitability metrics for Uniphos Enterprises Ltd are weak, with a return on equity (ROE) of 0.0001 and a return on assets (ROA) of 0.0001, both significantly below the industry median for Commodity Chemicals. The company reported a net income of INR 2.78 million on revenue of INR 1.12 billion, with an operating loss of INR 45.74 million, indicating poor operational efficiency. The company's revenue is concentrated in a single business segment, chemical trading, with no disclosed geographic diversification. This lack of diversification increases exposure to market volatility in the chemicals sector. The company's financial assets are primarily in listed securities, but no specific geographic or sectoral breakdown is provided. Uniphos Enterprises Ltd's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year and no forward-looking guidance provided. The company's operating cash flow is negative at INR 27.17 million, and free cash flow is INR -386.08 million, indicating a lack of cash generation from operations. The absence of capex or R&D investments further limits growth potential. Risk factors for Uniphos Enterprises Ltd include low liquidity risk and low dilution risk, with no immediate filing-based flags detected. However, the company's weak profitability and lack of operational cash flow raise concerns about long-term sustainability. No dilution sources were identified in recent filings, and no near-term dilution pressure is expected. Recent events include the filing of the 2023 annual report, which disclosed the company's financial position and lack of long-term debt. No material events or earnings calls were reported in the last quarter.

30-day price · UNPH+13.75 (+14.7%)
Low$87.51High$114.50Close$107.33As of12 May, 00:00 UTC
Profile
CompanyUniphos Enterprises Ltd
TickerUNPH.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Uniphos Enterprises Ltd is engaged in the trading of chemicals, primarily ethylenediamine, and operates as a core investment company (CIC) with financial assets concentrated in listed securities.

Classification. Uniphos Enterprises Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Uniphos Enterprises Ltd exhibits a highly liquid capital structure, with a current ratio of 8.83, indicating strong short-term liquidity. The company holds INR 71.19 million in cash and equivalents, while its total liabilities amount to INR 1.00 billion, with no long-term debt outstanding. This liquidity position is supported by a debt-to-equity ratio of 0.0, suggesting no leverage in its capital structure. Profitability metrics for Uniphos Enterprises Ltd are weak, with a return on equity (ROE) of 0.0001 and a return on assets (ROA) of 0.0001, both significantly below the industry median for Commodity Chemicals. The company reported a net income of INR 2.78 million on revenue of INR 1.12 billion, with an operating loss of INR 45.74 million, indicating poor operational efficiency. The company's revenue is concentrated in a single business segment, chemical trading, with no disclosed geographic diversification. This lack of diversification increases exposure to market volatility in the chemicals sector. The company's financial assets are primarily in listed securities, but no specific geographic or sectoral breakdown is provided. Uniphos Enterprises Ltd's growth trajectory is uncertain, with no disclosed revenue growth in the current fiscal year and no forward-looking guidance provided. The company's operating cash flow is negative at INR 27.17 million, and free cash flow is INR -386.08 million, indicating a lack of cash generation from operations. The absence of capex or R&D investments further limits growth potential. Risk factors for Uniphos Enterprises Ltd include low liquidity risk and low dilution risk, with no immediate filing-based flags detected. However, the company's weak profitability and lack of operational cash flow raise concerns about long-term sustainability. No dilution sources were identified in recent filings, and no near-term dilution pressure is expected. Recent events include the filing of the 2023 annual report, which disclosed the company's financial position and lack of long-term debt. No material events or earnings calls were reported in the last quarter.
Key takeaways
  • Uniphos Enterprises Ltd has a highly liquid balance sheet with a current ratio of 8.83 and no long-term debt.
  • The company's profitability is weak, with a return on equity of 0.0001 and an operating loss of INR 45.74 million.
  • Revenue is concentrated in a single business segment, chemical trading, with no geographic diversification.
  • The company lacks growth drivers, with no capex or R&D investments and negative free cash flow.
  • No immediate liquidity or dilution risks are present, but long-term sustainability is questionable due to poor operational performance.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.12B
Gross profit$8.0M
Operating income-$45.7M
Net income$2.8M
R&D
SG&A
D&A
SBC
Operating cash flow-$27.2M
CapEx
Free cash flow-$386.1M
Total assets$28.42B
Total liabilities$1.00B
Total equity$27.42B
Cash & equivalents$71.2M
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$27.42B
Net cash$71.2M
Current ratio8.8
Debt/Equity0.0
ROA0.0%
ROE0.0%
Cash conversion-9.8%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricUNPHActivity
Op margin-4.1%0.4% medp25 -8.0% · p75 16.0%below median
Net margin0.2%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin0.7%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue6.2% medp25 5.4% · p75 10.2%
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:11 UTC#7b4ae7a6
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:14 UTCJob: 5f59f5f7